Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 osteoblasts.

<h4>Background</h4>Icariin, a major active flavonoid glucoside, is widely used for the treatment of bone injury and rebuilding in the clinic because of its roles in suppressing osteoblastogenesis and promoting osteogenesis. The senescence-accelerated mouse SAMP6 was accepted as a useful...

Full description

Saved in:
Bibliographic Details
Main Authors: Bing Xu, Xueqiang Wang, Chengliang Wu, Lihe Zhu, Ou Chen, Xiaofeng Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0200367&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850044612086857728
author Bing Xu
Xueqiang Wang
Chengliang Wu
Lihe Zhu
Ou Chen
Xiaofeng Wang
author_facet Bing Xu
Xueqiang Wang
Chengliang Wu
Lihe Zhu
Ou Chen
Xiaofeng Wang
author_sort Bing Xu
collection DOAJ
description <h4>Background</h4>Icariin, a major active flavonoid glucoside, is widely used for the treatment of bone injury and rebuilding in the clinic because of its roles in suppressing osteoblastogenesis and promoting osteogenesis. The senescence-accelerated mouse SAMP6 was accepted as a useful murine model to reveal the mechanism of senile osteoporosis and the therapeutic mechanism of drug activity. However, little is known about the characteristics of SAMP6 osteoblasts and the associated regulatory roles of icariin.<h4>Methods</h4>We isolated and cultured osteoblasts from SAMP6 or SAMR1 mice and compared their proliferation, migration, and differentiation by performing the CCK-8 assay, cell counting assay, EdU staining, cell cycle analysis, ALP staining and activity measurement, Alizarin red staining, and RT-qPCR analysis to measure the levels of osteoblast markers, including RUNX2, Colla1 and Oc. To assess the effects of icariin on BMP-2-induced osteoblast differentiation, after BMP-2 treatment, osteoblast markers were analyzed by RT-qPCR and semi-quantitative Western blotting. The effects of icariin on connective tissue growth factor (CTGF) were measured by RT-qPCR. shRNA targeting CTGF mRNA was employed to knockdown its expression level in osteoblasts.<h4>Results</h4>The SAMP6 osteoblasts presented decreased the development and differentiation activity compared with SAMR1 osteoblasts, indicating that they are the potential mechanisms underlying age-associated disease. Moreover, SAMP6 osteoblasts presented upregulated CTGF compared with SAMR1 osteoblasts. Icariin enhanced BMP-2-induced osteoblast differentiation by downregulating CTGF expression, which tightly regulates osteoblast differentiation. By downregulating CTGF, icariin treatment upregulated phosphate-Smad1/5/8, indicating its activating effects on the BMP signaling pathway.<h4>Conclusion</h4>These results suggest that decreased osteoblast development and function potentially contributes to age-associated disease. Icariin exerts enhancing effects on BMP-2-mediated osteoblast development via downregulating CTGF.
format Article
id doaj-art-59ae5d0fe5f24403bdc3e082deffbce5
institution DOAJ
issn 1932-6203
language English
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-59ae5d0fe5f24403bdc3e082deffbce52025-08-20T02:54:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01137e020036710.1371/journal.pone.0200367Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 osteoblasts.Bing XuXueqiang WangChengliang WuLihe ZhuOu ChenXiaofeng Wang<h4>Background</h4>Icariin, a major active flavonoid glucoside, is widely used for the treatment of bone injury and rebuilding in the clinic because of its roles in suppressing osteoblastogenesis and promoting osteogenesis. The senescence-accelerated mouse SAMP6 was accepted as a useful murine model to reveal the mechanism of senile osteoporosis and the therapeutic mechanism of drug activity. However, little is known about the characteristics of SAMP6 osteoblasts and the associated regulatory roles of icariin.<h4>Methods</h4>We isolated and cultured osteoblasts from SAMP6 or SAMR1 mice and compared their proliferation, migration, and differentiation by performing the CCK-8 assay, cell counting assay, EdU staining, cell cycle analysis, ALP staining and activity measurement, Alizarin red staining, and RT-qPCR analysis to measure the levels of osteoblast markers, including RUNX2, Colla1 and Oc. To assess the effects of icariin on BMP-2-induced osteoblast differentiation, after BMP-2 treatment, osteoblast markers were analyzed by RT-qPCR and semi-quantitative Western blotting. The effects of icariin on connective tissue growth factor (CTGF) were measured by RT-qPCR. shRNA targeting CTGF mRNA was employed to knockdown its expression level in osteoblasts.<h4>Results</h4>The SAMP6 osteoblasts presented decreased the development and differentiation activity compared with SAMR1 osteoblasts, indicating that they are the potential mechanisms underlying age-associated disease. Moreover, SAMP6 osteoblasts presented upregulated CTGF compared with SAMR1 osteoblasts. Icariin enhanced BMP-2-induced osteoblast differentiation by downregulating CTGF expression, which tightly regulates osteoblast differentiation. By downregulating CTGF, icariin treatment upregulated phosphate-Smad1/5/8, indicating its activating effects on the BMP signaling pathway.<h4>Conclusion</h4>These results suggest that decreased osteoblast development and function potentially contributes to age-associated disease. Icariin exerts enhancing effects on BMP-2-mediated osteoblast development via downregulating CTGF.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0200367&type=printable
spellingShingle Bing Xu
Xueqiang Wang
Chengliang Wu
Lihe Zhu
Ou Chen
Xiaofeng Wang
Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 osteoblasts.
PLoS ONE
title Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 osteoblasts.
title_full Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 osteoblasts.
title_fullStr Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 osteoblasts.
title_full_unstemmed Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 osteoblasts.
title_short Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 osteoblasts.
title_sort flavonoid compound icariin enhances bmp 2 induced differentiation and signalling by targeting to connective tissue growth factor ctgf in samp6 osteoblasts
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0200367&type=printable
work_keys_str_mv AT bingxu flavonoidcompoundicariinenhancesbmp2induceddifferentiationandsignallingbytargetingtoconnectivetissuegrowthfactorctgfinsamp6osteoblasts
AT xueqiangwang flavonoidcompoundicariinenhancesbmp2induceddifferentiationandsignallingbytargetingtoconnectivetissuegrowthfactorctgfinsamp6osteoblasts
AT chengliangwu flavonoidcompoundicariinenhancesbmp2induceddifferentiationandsignallingbytargetingtoconnectivetissuegrowthfactorctgfinsamp6osteoblasts
AT lihezhu flavonoidcompoundicariinenhancesbmp2induceddifferentiationandsignallingbytargetingtoconnectivetissuegrowthfactorctgfinsamp6osteoblasts
AT ouchen flavonoidcompoundicariinenhancesbmp2induceddifferentiationandsignallingbytargetingtoconnectivetissuegrowthfactorctgfinsamp6osteoblasts
AT xiaofengwang flavonoidcompoundicariinenhancesbmp2induceddifferentiationandsignallingbytargetingtoconnectivetissuegrowthfactorctgfinsamp6osteoblasts